...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer

I would just like to bring up the fact that I believe that ZEL or Zenith Epigenetics Limited the subsidiary of ZCC is the one developing the drug which is being spoken of the most ZEN3694 (I believe but it could be another one).

As such I believe ZEL would be the company to be invested in by a Pharma (possibly Pfizer).

I also remember ZEL being set up and I also remember a statement being made by DM at that time that part of the thinking behind setting up ZEL was that the shares of ZEL could be distributed to all of the shareholders of ZCC as being a tax efficient way of getting their rightful interest in ZEL into their hands. 

After the distribution we would each have some shares of ZEL in our hands at a low Capital cost and could either sell our shares to the Pharma investor if they wished to become the owners of 100% and pay a lot in Capital Gains tax or we could hold our shares in ZEL and the Pharma could invest into ZEL and then list ZEL on a US exchange or give us shares of itself for our shares of ZEL (that would result in a tax effective way of getting its shares in our hands and we could collect dividends from them into the future without having to pay what we accountants call "Too Damn Much Tax" which of course is better than having to pay "Too Damn Little Tax"

All of this is of course putting the cart before the horse or counting our chickens before they hatch but it is a lot of fun to speculate and to hope for!

Share
New Message
Please login to post a reply